Emerging preclinical, compassionate-use, and randomized trial data suggest phage-antibiotic combinations may benefit select patients with multidrug-resistant infections, yet critical gaps in standardization and evidence remain.
Amer El-Ghali, PharmD
Advertisement
El-Ghali is an assistant professor at the University of New Mexico College of Pharmacy. (ORCID 0000-0003-1744-0048)
Articles by Amer El-Ghali, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
ASM Microbe Conference: Bringing the Microbiology Community Together
2
Wastewater Surveillance’s Role in Identifying Measles Outbreaks
3
Aging With HIV: Managing Comorbidities in a Population That Has Outlived Its Prognosis
4
What the FDA Approval of Buleviratide (Hepcludex) Means for Chronic Hepatitis D Treatment
5